A-B-C, Correction

The market hits just keep coming for biotech.

First, it was this (RFK Jr., nominated, then confirmed), then it was this, and now, the latest is this.

While the financial press toys with the idea ‘the worst is over‘, (which might be true), with biotech, price action itself says it may be preparing for its next leg … lower.

Biotech XBI, Hourly

We’re drilling down to the hourly; it shows (as of 12:24 p.m., EST) a Fibonacci a-b-c, corrective retrace.

Wave ‘a’, was the massive short squeeze.

Wave ‘b’ was a test of the lows; then on to wave ‘c’, the same (net) distance as wave ‘a’, making it a 1:1 (potentially complete) corrective move.

Also note the ‘alternation’.

Wave ‘a’, was essentially straight up. Then, wave ‘c’ alternates and is a labored slow process, ratcheting higher.

We’re at The Danger Point®, where the risk of a short position is least (not advice, not a recommendation).

Currently short, Trade: LABD-25-08, with stop at the LABD, session low (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279